Background To investigate the safety and effectiveness of non-viscoelastic agent technique for EVO-ICL implantation. Methods A total of 181 myopia eyes that underwent non-toric ICL without viscoelastic agent through single incision from Beijing Tongren Hosipital were included. An analysis was conducted on the quantity of haptics that were initially implanted intraoperatively into the posterior chamber. Intraocular pressure (IOP) was evaluated at before and 2 h,24 h,1week,6month after surgery. Anterior chamber volume(ACV), anterior chamber depth(ACD), anterior chamber angle(ACA), pupil diameter(PD) and corneal densitometry density (ECD) were evaluated at before and 24 h postoperatively. Refractive outcomes were investigated at before, 24 h ,7 days and 6months. Vault was evaluated at 24 h ,7 days and 6months. Results The efficacy and safety indices were 1.30 +/- 0.32 and 1.31 +/- 0.32, respectively. Of 181 eyes, 99 eyes received 4 haptics on the first attempt without any adjustment, and 72 eyes received lens alignment without an viscoelastic agent. The success rate of the viscoelastic agent free procedure was 94.5%. Two hours postoperatively, IOP was 17.41 +/- 3.77 mmHg, which was significantly higher than baseline value (t = 8.930, P < 0.000), however there was no significant difference between preoperative IOP and IOP at 1 day ,1 week and 6 months postoperatively. The ECD changed from 2895.52 +/- 253.73 cells/mm2 preoperatively to 2873.66 +/- 244.17 cells/mm2 at 1 day and 2882.63 +/- 239.97 postoperatively, and the difference was not statistically significant (t = 1.811, P = 0.072). The ACA was narrowed by 42% on the first day. Conclusion The pure viscoelastic agent free technique is an efficient and safe way for ICL implantation. It can be a safer method of ICL implantation because of it reduces the risk of complications associated with ocular hypertension at the early postoperative stages. Trial registration Chinese Clinical Trial Registry (ChiCTR2000036335) at August 20, 2020.
基金:
Research and transformation application of capital clinical diagnosis and treatment technology by Beijing Municipal Commission of Science and Technology [Z201100005520043]; Priming scientific research foundation for the junior researcher in Beijing Tongren Hospital, Capital Medical University [2019-YJJ-ZZL-042]
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Li Yu,Zhang Fengju,Xiong Ying.Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent[J].BMC OPHTHALMOLOGY.2024,24(1):doi:10.1186/s12886-024-03587-3.
APA:
Li, Yu,Zhang, Fengju&Xiong, Ying.(2024).Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent.BMC OPHTHALMOLOGY,24,(1)
MLA:
Li, Yu,et al."Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent".BMC OPHTHALMOLOGY 24..1(2024)